It's been a banner year so far for Monopar Therapeutics Inc. (MNPR), whose share price has catapulted as much as 145% this year.This clinical-stage company's lead drug candidate is ALXN1840, a once-daily, oral medicine in development for the treatment of Wilson disease.Wilson disease is a rare, progressive genetic disorder that disrupts the body's ability to eliminate excess copper, resulting in t...
For comments and feedback contact: editorial@rttnews.com
May 15, 2026 15:25 ET Apart from the confirmation of Kevin Warsh as the next Fed chair, the main news on the economics front this week included key price data from the U.S. and the first quarter economic growth figures from major economies. Both consumer prices and producer costs have started to reflect the effect of supply shocks due to the Middle East conflict. In Europe, GDP data was in focus, while inflation data from China dominated the news flow in Asia.